Hypoglycemic Agents - Therapeutic use
Research News and Information

Saturday, November 21, 2009

Three-year efficacy of complex insulin regimens in type 2 diabetes.

20 Oct 2009 BACKGROUND: Evidence supporting the addition of specific insulin regimens to oral therapy in patients with type 2 diabetes mellitus is limited. METHODS: In this 3-year open-label, multicenter trial, we evaluated 708 patients who had suboptimal ... Read more...

Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.

5 Oct 2009 CONTEXT: National public insurance for drugs is often based on evidence of comparative effectiveness and cost-effectiveness. This study describes how that evidence has been used across 3 jurisdictions (Australia, Canada, and Britain) that have been ... Read more...

Pharmacotherapy of hyperglycemia.

29 Sep 2009 Type 2 diabetes mellitus (T2DM) is a chronic, progressive disorder that affects more than 230 million people worldwide and is expected to affect 366 million by 2030. Both the prevalence of T2DM and the cost of its long term complications has driven ... Read more...

Latest indexed articles for 'Hypoglycemic Agents - Therapeutic use'

These are the very latest articles for this heading:

• Obesity and survival among patients with pancreatic cancer. 26 Oct 2009
• Three-year efficacy of complex insulin regimens in type 2 diabetes. 20 Oct 2009
• Variation in event rates in trials of patients with type 2 diabetes. 19 Oct 2009
• Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. 10 Oct 2009
• Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. 5 Oct 2009
• Pharmacotherapy of hyperglycemia. 29 Sep 2009
• Dapagliflozin: where does it fit in the treatment of type 2 diabetes? 29 Sep 2009
• Metformin: diamonds are forever. 29 Sep 2009
• Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes. 29 Sep 2009
• Early Origins of polycystic ovary syndrome: hypotheses may change without notice. 29 Sep 2009
• Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. 29 Sep 2009
• Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009
• Gestational diabetes--whom do we treat? 29 Sep 2009
• A multicenter, randomized trial of treatment for mild gestational diabetes. 29 Sep 2009
• Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. 19 Sep 2009
• Glycaemic control in hospitalised diabetic patients at the University Hospital Basel in 2002 and in 2005. 17 Sep 2009
• Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. 14 Sep 2009
• [Self-monitoring blood glucose in patients with type 2 diabetes. Who should do this, how often, when and under which conditions?] 8 Sep 2009
• [Polycystic ovary syndrome. Diet helps control hormone chaos] 8 Sep 2009
• Design, statistical analysis and sample size calculation of a phase IIb/III study of linagliptin versus voglibose and placebo. 3 Sep 2009

See a longer list of these articles.

Technical information about 'Hypoglycemic Agents'

Definition: Agents which lower the blood glucose level.

Registry Number: 0

Descriptor UI: D007004

Alternative terms: Hypoglycemic Agents; Agents, Hypoglycemic; Hypoglycemics; Hypoglycemic Drugs; Drugs, Hypoglycemic; Antidiabetics; Antidiabetic Drugs; Drugs, Antidiabetic; Antidiabetic Agents; Agents, Antidiabetic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.422;

Online Note: use HYPOGLYCEMIC AGENTS to search ANTIDIABETICS 1966-75

History Note: 76; was NON MESH 1975, was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75